GB0423041D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0423041D0
GB0423041D0 GB0423041A GB0423041A GB0423041D0 GB 0423041 D0 GB0423041 D0 GB 0423041D0 GB 0423041 A GB0423041 A GB 0423041A GB 0423041 A GB0423041 A GB 0423041A GB 0423041 D0 GB0423041 D0 GB 0423041D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0423041A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0423041A priority Critical patent/GB0423041D0/en
Publication of GB0423041D0 publication Critical patent/GB0423041D0/en
Priority to TW094117058A priority patent/TW200600086A/en
Priority to EP08154684A priority patent/EP1992623A1/en
Priority to EP05747241A priority patent/EP1756076B1/en
Priority to CA002566951A priority patent/CA2566951A1/en
Priority to DE602005022859T priority patent/DE602005022859D1/en
Priority to PCT/GB2005/002166 priority patent/WO2005121110A1/en
Priority to US11/628,448 priority patent/US7745475B2/en
Priority to AT05747241T priority patent/ATE477249T1/en
Priority to NZ551623A priority patent/NZ551623A/en
Priority to AU2005251990A priority patent/AU2005251990B2/en
Priority to MXPA06014128A priority patent/MXPA06014128A/en
Priority to JP2007514127A priority patent/JP4860606B2/en
Priority to RU2006145204/04A priority patent/RU2403246C2/en
Priority to KR1020067027324A priority patent/KR20070024650A/en
Priority to BRPI0511808-5A priority patent/BRPI0511808A/en
Priority to ES05747241T priority patent/ES2347451T3/en
Priority to ARP050102265A priority patent/AR049139A1/en
Priority to MYPI20052532A priority patent/MY144048A/en
Priority to UY28936A priority patent/UY28936A1/en
Priority to SA05260154A priority patent/SA05260154B1/en
Priority to IL179389A priority patent/IL179389A0/en
Priority to NO20070032A priority patent/NO20070032L/en
Priority to HK07106859.0A priority patent/HK1102091A1/en
Priority to US12/336,170 priority patent/US20090253676A1/en
Ceased legal-status Critical Current

Links

GB0423041A 2004-06-05 2004-10-16 Chemical compounds Ceased GB0423041D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0423041A GB0423041D0 (en) 2004-10-16 2004-10-16 Chemical compounds
TW094117058A TW200600086A (en) 2004-06-05 2005-05-25 Chemical compound
ES05747241T ES2347451T3 (en) 2004-06-05 2005-06-01 DERIVATIVES OF HETEROARIL BENZAMIDA FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES.
JP2007514127A JP4860606B2 (en) 2004-06-05 2005-06-01 Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
RU2006145204/04A RU2403246C2 (en) 2004-06-05 2005-06-01 Heteroarylbenzamyl derivatives for application as glucokinase (glk) activators in treatment of diabetes
CA002566951A CA2566951A1 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
DE602005022859T DE602005022859D1 (en) 2004-06-05 2005-06-01 Heteroarylbenzamide derivatives for use as glk activators in the treatment of diabetic
PCT/GB2005/002166 WO2005121110A1 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US11/628,448 US7745475B2 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives as GLK activators
AT05747241T ATE477249T1 (en) 2004-06-05 2005-06-01 HETEROARYLBENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
NZ551623A NZ551623A (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
AU2005251990A AU2005251990B2 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
MXPA06014128A MXPA06014128A (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.
EP08154684A EP1992623A1 (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
EP05747241A EP1756076B1 (en) 2004-06-05 2005-06-01 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
KR1020067027324A KR20070024650A (en) 2004-06-05 2005-06-01 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
BRPI0511808-5A BRPI0511808A (en) 2004-06-05 2005-06-01 compound or a salt, prodrug or solvate thereof, use of a compound method for treating glk-mediated diseases, and process for the preparation of a compound
UY28936A UY28936A1 (en) 2004-06-05 2005-06-02 GROUP OF BENZOIL-AMINO-HETEROCICLILO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, USEFUL FOR TREATMENT OF GLUCOQUINASE-AIDED DISEASES (GQ)
ARP050102265A AR049139A1 (en) 2004-06-05 2005-06-02 COMPOUNDS DERIVED FROM BENZAMIDS N - HETEROCICLIL - REPLACED AS ACTIVATORS OF GLUCOQUINASE (GLK), METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE AS A MEDICATION IN THE TREATMENT OF TYPE II DIABETES.
MYPI20052532A MY144048A (en) 2004-06-05 2005-06-02 Chemical compound
SA05260154A SA05260154B1 (en) 2004-06-05 2005-06-04 Heteroaryl Benzamide Derivatives Useful as GLK Activators in the Treatment of Diabetes
IL179389A IL179389A0 (en) 2004-06-05 2006-11-19 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
NO20070032A NO20070032L (en) 2004-06-05 2007-01-03 Hetroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
HK07106859.0A HK1102091A1 (en) 2004-06-05 2007-06-27 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US12/336,170 US20090253676A1 (en) 2004-06-05 2008-12-16 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0423041A GB0423041D0 (en) 2004-10-16 2004-10-16 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0423041D0 true GB0423041D0 (en) 2004-11-17

Family

ID=33462865

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0423041A Ceased GB0423041D0 (en) 2004-06-05 2004-10-16 Chemical compounds

Country Status (1)

Country Link
GB (1) GB0423041D0 (en)

Similar Documents

Publication Publication Date Title
GB0414438D0 (en) Chemical compounds
EP1713775A4 (en) Chemical compounds
GB0412467D0 (en) Chemical compounds
EP1793826A4 (en) Chemical compounds
EP1708697A4 (en) Chemical compounds
EP1784185A4 (en) Chemical compounds
EP1778231A4 (en) Chemical compounds
GB0406280D0 (en) Chemical compounds
EP1838312A4 (en) Chemical compounds
GB0413389D0 (en) Chemical compounds
GB0412072D0 (en) Chemical compounds
GB0412468D0 (en) Chemical compounds
GB0413953D0 (en) Chemical compounds
GB0413955D0 (en) Chemical compounds
GB0427328D0 (en) Chemical compounds
GB0427699D0 (en) Chemical compounds
GB0411595D0 (en) Chemical compounds
GB0424528D0 (en) Chemical compounds
GB0409494D0 (en) Chemical compounds
GB0411592D0 (en) Chemical compounds
GB0409567D0 (en) Chemical compounds
GB0413970D0 (en) Chemical compounds
GB0403781D0 (en) Chemical compounds
GB0411998D0 (en) Chemical compounds
GB0406618D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)